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I-24 THE ROLE OF ACTIVATED SYNOVIAL MACROPHAGES IN
OSTEOARTHRITIS
J. Bondeson. Department of Rheumatology, Cardiff, UNITED
KINGDOM
Purpose: To investigate the role of synovial macrophages in driving
inﬂammatory and degradative responses in osteoarthritis.
Methods: We have used of a model of cultures of synovial cells from
digested OA (or RA) synovium. These cells spontaneously produce both
pro- and anti-inﬂammatory cytokines, including TNFa, Il-1 and Il-10, as
well as the MMPs. If adenoviral gene transfer is used in this model, all
cell types are effectively infected, including the synovial macrophages.
Speciﬁc depletion of synovial macrophages from these cultures of OA
synovial cells could be achieved using anti-CD14-conjugated magnetic
beads. In other experiments, speciﬁc neutralisation of the endogenous
production of TNFa and/or Il-1b was done using incubation with the p75
TNF soluble receptor Ig fusion protein etanercept (Enbrel), a neutralizing
anti-Il-1b antibody, or a combination of Enbrel and anti-Il-1b.
Results: Using an adenovirus transferring the inhibitory subunit IúBa, it
was possible to selectively inhibit NFúB in synovial cell cocultures. While
macrophage-produced TNFa and Il-1b was strongly NFúB dependent in
the RA synovium, adenoviral transfer of IúBa did not affect Il-1b produc-
tion and had only a partial effect on TNFa. Effects on other cytokines
were similar in RA and OA synovium, with Il-6 and Il-8 both being NFúB
dependent. In addition, MMP-1,3, and 13 were strongly NFúB dependent
in both RA and OA, but TIMP-1 was not.
CD14+-depleted cultures of OA synovial cells no longer produced sig-
niﬁcant amounts of macrophage-derived cytokines like TNFa and Il-1b.
There was also signiﬁcant inhibition of several cytokines produced mainly
by synovial ﬁbroblasts, like Il-6 and Il-8, and signiﬁcant downregulation
of MMP-1 and MMP-3. To investigate the mechanisms involved in this
macrophage driven stimulation of inﬂammatory and degradative pathways
in the OA synovium, we went on to use speciﬁc neutralisation of TNFa
and/or Il-1b in the cultures of OA synovial cell. As could be expected,
TNFa production was effectively neutralised by Enbrel treatment, and Il-1b
by treatment with the anti-Il-1b antibody. There was no effect of Enbrel
on Il-1b production, nor did the anti-Il-1b antibody affect the production of
TNFa. Both Enbrel and the anti-Il-1b antibody inhibited Il-6 and Il-8, with
60% inhibition achieved when both Il-1b and TNFa were neutralized.
Neither Enbrel nor the anti-Il-1b antibody had an impressive effect on
MMP-1 and MMP-13, but combination of the two led to signiﬁcant in-
hibition both on the mRNA and protein levels. ADAMTS4 mRNA was
signiﬁcantly inhibited by Enbrel, and more potently inhibited by a combi-
nation of Enbrel and the anti-Il-1b antibody, but there was no effect on
ADAMTS5 mRNA.
Conclusions: The differential effect of NFúB downregulation on the
spontaneous production of TNFa and Il-1b in RA and OA would indicate
that the regulation of at least one key intracellular pathway differs funda-
mentally between these diseases. Both TNFa and Il-1b have functional
NFúB elements on their promoters and in various macrophage models,
there are both NFúB dependent and NFúB independent ways of inducing
TNFa and Il-1b.
Depletion of OA synovial macrophages leads to potent downregulation of
several ﬁbroblast-produced cytokines and MMPs, as well as ADAMTS4.
This effect is mediated via a combination of Il-1b and TNFa. This ﬁnding,
along with recent results indicating a key role for macrophages in murine
models of OA, would point out synovial macrophages and their cytokines
as potential therapeutic targets in human OA.
In contrast to the situation in RA, Il-1b is not TNFa driven in the OA
synovium. This ﬁnding indicates yet another difference in macrophage
cytokine biology between RA and OA: whereas TNFa is the ‘boss
cytokine’ in the RA synovium, regulating the production of Il-1b, there
is a redundancy between these two cytokines in the OA synovium.
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Oxford, Oxford, UNITED KINGDOM
Purpose: Synovial Fluid (SF) is dialysate of plasma, which, in uninﬂamed
joints, contains relatively few inﬂammatory cells. In joint conditions such
as rheumatoid arthritis (RA), pyrophosphate arthropathy (PPA), and some
cases of inﬂammatory osteoarthritis (OA), the SF contains numerous
inﬂammatory cells including macrophages, neutrophil polymorphs and
lymphocytes.
Methods: Osteoclasts can be formed from monocytes and macrophages
when these cells are cultured in the presence of macrophage-colony
stimulating factor (M-CSF) and soluble receptor activator for nuclear
factor úB ligand (RANKL). Osteoclasts exhibit a number of speciﬁc
phenotypic characteristics, being CD14−, vitronectin receptor (VNR) +,
tartrate-resistant acid phosphatase (TRAP) + and are uniquely capable
of lacunar bone resorption.
Results: It has been shown that SF macrophages (CD14+) isolated
from the knee joint SF of patients with OA, RA and PPA, when cul-
tured with M-CSF and RANKL, can differentiate into multinucleated cells
which express the cytochemical and functional features of osteoclasts.
Under these conditions more resorption is seen in RA than OA SF
macrophage cultures. Macrophage-osteoclast differentiation can also oc-
cur by a RANKL-independent mechanism in which other TNF superfamily
members, such as tumour necrosis factor-a (TNFa) and LIGHT, substitute
for RANKL. LIGHT (but not TNFa) is present in high concentration in
inﬂammatory (compared with non-inﬂammatory) OA synovial ﬂuid, and
LIGHT-treated OA SF macrophage cultures induces osteoclast formation
and resorption equal to that seen in RA SF macrophage cultures.
Conclusions: SF macrophages are thus capable of differentiating into
mature osteoclasts capable of lacunar resorption, and signiﬁcantly more
osteoclast formation occurs in SF containing increased numbers of in-
ﬂammatory cells. The increase in macrophage number and the amount
of LIGHT and other osteoclastogenic factors in inﬂammatory SF, may play
a role in joint destruction in OA and other arthritic conditions by promoting
SF macrophage-osteoclast differentiation.
I-26 ACTIVATION OF INFLAMMATORY SIGNALLING IN
CARTILAGE BY SOLUBLE AND PHYSICAL STIMULI
J. Saklatvala. Imperial College Kennedy Inst., London, UNITED
KINGDOM
Purpose: The ability of soluble mediators such as proinﬂammatory
cytokines (Il-1, TNF) or bacterial lipopolysaccharide (LPS) to activate
inﬂammatory signalling pathways in cartilage is well known. Typically
such stimuli activate NF úB and the three MAP kinase pathways to
cause expression of inﬂammatory response genes and the molecular
mechanisms coupling the cell surface receptors for the soluble stimuli
to the downstream pathways are known in some detail. One important
result is that the chondrocytes are activated to degrade their extracellular
matrix. There is good evidence that such proteolytic degradation of
cartilage matrix is an important early feature of osteoarthritis but to what
extent the degenerative process is driven by known soluble inﬂammatory
stimuli is unclear. It is less widely appreciated that inﬂammatory signalling
pathways are also rapidly activated by simple physical injury to tissues;
such a process is potentially relevant to osteoarthritis, where tissue injury
is a well-known predisposing factor.
Simple wounding of porcine articular cartilage with a scalpel, either
by scoring its surface, or dissecting tissue explants, rapidly activates
the MAP kinase and NF úB pathways and also induces inﬂammatory
response genes. In part, this cell activation is due to release of basic
ﬁbroblast growth factor (FGF-2) which is stored in a pericellular pool
bound to perlecan. However FGF-2, while augmenting the response, does
not itself activate NF úB or the stress kinase c-jun N-terminal kinase
(JNK). The activation of JNK, for example, occurs within seconds of
injury. It has been proposed that damaged cells release contents that
are pro-inﬂammatory (e.g., heat shock proteins); however, we have been
unable to ﬁnd evidence of any soluble factor released from wounded
cartilage that causes inﬂammatory signalling as indicated by JNK activity.
Rather, chondrocytes seem to directly ‘sense’ matrix injury. We have
explored the possibility that such sensing could be integrin mediated.
Although activation and phosphorylation of focal adhesion kinase (FAK)
occurs upon sharp injury to the tissue, there is also additional major
tyrosine phosphorylation of cellular proteins, some of it consistent with
major activation of src family kinase(s). Experiments with inhibitors of
protein kinases suggest that the FAK/src activation is not upstream of
inﬂammatory signalling.
Our current model is that disruption of the extracellular matrix (and
probably collagen ﬁbres in particular) directly activates multiple parallel
cell signalling pathways including src and the MAP kinases. Our lack of
understanding of how tissue damage activates inﬂammatory signalling is
a major gap in our knowledge of the inﬂammatory response.
